- Home
- BETR vs OABI Comparison
BETR vs OABI Comparison
Compare BETR & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BETR | OABI |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.0M | 294.3M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BETR | OABI |
|---|---|---|
| Price | $13.06 | $4.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $40.00 | $4.50 |
| AVG Volume (30 Days) | 659.9K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.88 | 6.56 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $164,872,000.00 | $18,666,000.00 |
| Revenue This Year | $55.02 | $52.42 |
| Revenue Next Year | $65.66 | $64.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.97 | N/A |
| 52 Week Low | $11.11 | $1.32 |
| 52 Week High | $94.06 | $5.43 |
Technical Indicators
Market Signals| Indicator | BETR | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 51.56 |
| Support Level | $11.55 | $1.71 |
| Resistance Level | $15.30 | $5.43 |
| Average True Range (ATR) | 1.28 | 0.33 |
| MACD | 0.45 | -0.13 |
| Stochastic Oscillator | 50.17 | 4.28 |
Price Performance
Historical ComparisonAbout BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.
About OABI OmniAb Inc.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.